Chilton Capital Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,000
Closed -$140K 534
2024
Q4
$140K Hold
2,000
0.01% 249
2024
Q3
$210K Hold
2,000
0.01% 222
2024
Q2
$284K Sell
2,000
-1,000
-33% -$115K 0.01% 200
2024
Q1
$335K Buy
3,000
+1,000
+50% +$119K 0.02% 195
2023
Q4
$259K Buy
+2,000
New +$276K 0.01% 214

Other funds holding ACLS

Chilton Capital Management's ACLS Position: Q1 2025 in Review

Chilton Capital Management sold out of Axcelis (ACLS) in Q1 2025, closing a stake of 2,000 shares — an estimated $140K sold.

Chilton Capital Management first reported a position in ACLS in Q4 2023 and held it in 5 quarters. The position peaked at $335K in Q1 2024. 306 funds tracked by Wall St. Rank hold ACLS as of Q1 2025.

  • Chilton Capital Management reported no remaining Axcelis position as of Q1 2025 after selling out during the quarter.
  • Chilton Capital Management sold 2,000 Axcelis shares in Q1 2025, an estimated $140K.
  • Chilton Capital Management first reported a position in Axcelis in Q4 2023 and held it in 5 quarters.
  • Chilton Capital Management's Axcelis position peaked at $335K in Q1 2024.
  • 306 funds tracked by Wall St. Rank held Axcelis as of Q1 2025.

Based on Chilton Capital Management's 13F filing for Q1 2025, filed 29 Apr 2025.